Company intelligence / Profile preview
Aviex Technologies LLC
United Statesaviextechnologiesllc.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Aviex Technologies LLC develops potent oral and multi-modality vaccines using a novel patented platform designed for both preventative and therapeutic use against a broad range of human and animal infectious diseases caused by bacterial and parasitic pathogens. No clinical results have been published as of the latest available information.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Oral vaccinesMulti-modality vaccine delivery
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Aviex Technologies LLC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aviex Technologies LLC.